Excited to share our work showing that ROR2 regulates proteostasis in cardiomyocytes, with excess ROR2 disrupting cardiomyocyte structure leading to RV failure!
#Circulation#RVFailure
https://t.co/wHgC1Jm6rM
Thank you to co-author @itskristinali and senior authors Jonathan Edwards and Zolt Arany @AranyLab. Also to @patrick_ellinor for helping with snRNA-seq, @LavineLab for pediatric data, Kenneth B. Margulies for adult samples, @PennCVI, and many others.
The result: most transcriptional changes happen before failure. While function is still preserved, the myocardium is already far from “normal.”
More broadly, I think this challenges the idea that RV failure is simply accompanied by progressively greater transcriptional changes.
We're proud to share the launch of a new research institute: The CHOP Cardiovascular Institute, led by Dr. Daniel Kelly, Director of the @PennCVI, will develop novel research programs & drive scientific discovery to improve pediatric cardiovascular care: https://t.co/Q29y3ypugn
Proud to be part of new @ChildrensPhila Frontier Program: Advanced Cardiac Therapies for Heart Failure Patients. co-PI with Joe Rossano, Katsuhide Maeda. Major involvement from @JonEdwardsMD. Research focus on understanding the enigmatic right heart failure..
Novel validated risk score predicts mortality of ED VAD patients using identifiable demographic and clinical factors @JEdelsonMD#AHAJournals https://t.co/oRQ0iXFqHb
Edelson and colleagues characterize the growing financial burden, and high risk of death, of ambulatory VAD patients presenting to the ED. https://t.co/UlBoAEm9xh @JEdelsonMD#AHAJournals
Happy to share Nora's paper now in @eLife. Surprise to us: cardiac ECs express genes like troponin, myosin, titin, and do so by keeping open chromatin in those genes. NOT contamination! chromatin closes upon ex vivo culture of ECs... https://t.co/WhvAkO7xB8
Noncanonical WNT Activation in Human Right Ventricular Heart Failure https://t.co/rGjumIaMsA Or, as I like to say, WNT the right ventricle's had enough!